The optimal use of PEG-asparaginase in relapsed ALL--lessons from the ALLR3 Clinical Trial

Affiliations

• ¹ Children's Cancer Group, Manchester Academic Health Sciences Centre, Institute of Cancer, University of Manchester, Manchester, UK.
• ² Department of Haematology-Oncology, SA Pathology at Women's and Children's Hospital and University of Adelaide, Adelaide, South Australia, Australia.
• ³ 1] Childrens Hospital, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands [2] Dutch 17 Childhood Oncology Group, The Hague, The Netherlands.
• ⁴ Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
• ⁵ 1] Children's Cancer Group, Manchester Academic Health Sciences Centre, Institute of Cancer, University of Manchester, Manchester, UK [2] Department of Paediatric Oncology, Tata Translational Cancer Research Centre, Kolkata, India.